Cargando…
COVID-19 pandemic and adrenals: deep insights and implications in patients with glucocorticoid disorders
PURPOSE: Coronavirus disease-19 (COVID-19) has spread throughout the world. It was initially defined as a potentially severe syndrome affecting the respiratory tract, but it has since been shown to be a systemic disease with relevant extrapulmonary manifestations that increase mortality. The endocri...
Autores principales: | Cozzolino, Alessia, Hasenmajer, Valeria, Newell-Price, John, Isidori, Andrea M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462567/ https://www.ncbi.nlm.nih.gov/pubmed/37338722 http://dx.doi.org/10.1007/s12020-023-03411-w |
Ejemplares similares
-
Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection
por: Isidori, Andrea M, et al.
Publicado: (2020) -
Non-Canonical Effects of ACTH: Insights Into Adrenal Insufficiency
por: Hasenmajer, Valeria, et al.
Publicado: (2021) -
Glycometabolic Alterations in Secondary Adrenal Insufficiency: Does Replacement Therapy Play a Role?
por: Graziadio, Chiara, et al.
Publicado: (2018) -
Susceptibility and characteristics of infections in patients with glucocorticoid excess or insufficiency: the ICARO tool
por: Minnetti, Marianna, et al.
Publicado: (2022) -
COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency
por: Isidori, A. M., et al.
Publicado: (2020)